CD8A and neoplasm: By depleting regulatory T cells and myeloid-derived suppressor cells (MDSCs), while enhancing CD8/Treg ratios and cytotoxic T lymphocyte activation, we showed how 225Ac-NM600 transforms the tumor microenvironment into a more immunologically active state.